pomalidomide has been researched along with Acute Lymphoid Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bührer, C; Costa-Blechschmidt, C; Fichtner, I; Henze, G; Moderegger, E; Pfau, M; Seeger, K; Shalapour, S; Taube, T; van Landeghem, FK; Wellmann, S; Zelmer, A | 1 |
1 other study(ies) available for pomalidomide and Acute Lymphoid Leukemia
Article | Year |
---|---|
The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivo.
Topics: Animals; Apoptosis; Blood Vessels; Caspase 3; Cell Proliferation; Child, Preschool; Female; Humans; Infant; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stromal Cells; Thalidomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2006 |